Gland Pharma Gains After USFDA Inspection: Analysis for Retail Investors and Finance Students
Introduction: Gland Pharma’s recent announcement that it has received a favorable Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its Pashamylaram facility in Hyderabad, India, is a significant development that could have positive implications for the company’s future growth prospects. The EIR indicates that the facility complies with the USFDA’s […]